Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Prediction Markets
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • General

Autolus Therapeutics Announces Collaboration With Bristol Myers Squibb For Use Of Autolus’ Safety Switch System

By Bill Haddad
October 4, 7:09 AM
- Bristol Myers Squibb to receive access to Autolus’ RQR8 safety switch for use in cell therapy programs - - Autolus to receive an upfront payment, with potential for near term option exercise fees and development

AUTL

Read More
2 minute read
  • Insider Trades
  • Markets
  • News
  • Small Cap
  • Trading Ideas

Insiders Selling Nasdaq, Bristol-Myers Squibb And This Consumer Defensive Stock

By Lisa Levin
September 23, 11:05 AM
The Nasdaq Composite dropped by around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

BMY

Read More
1 minute read
  • Long Ideas
  • Media
  • Trading Ideas

Bristol-Myers Squibb, Cash, Cheniere Energy And This Tech Company Are CNBC’s Final Trades

By Priya Nigam
September 23, 9:01 AM
On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners said Bristol-Myers Squibb Co (NYSE: BMY) has a “good dividend yield” and is a &l

BMY

Read More
1 minute read
  • General
  • Media
  • Trading Ideas

Salesforce Is Among Thursday’s CNBC ‘Fast Money’ Final Trades

By AJ Fabino
September 22, 1:37 PM
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined using Benzinga Pro’s News Tool. Benzinga Pro users can access this information by using the News tool on any workstation.

BMY

Read More
1 minute read
  • Dividends
  • News
  • Trading Ideas

CNBC Halftime Report Final Trades: Bristol-Myers Squibb, Salesforce & Cheniere Energy

By Benzinga Newsdesk
September 22, 1:00 PM
- CNBC

BMY

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks

Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial

By Vandana Singh
September 22, 7:22 AM
Nanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime for inoperable locoregional recurrent or recurrent and metastatic head and neck squamous cell carcinoma that is resistant to prior immunotherapy. 

BMY

Read More
2 minute read
  • Markets
  • Options

What Are Whales Doing With Bristol-Myers Squibb

By Benzinga Insights
September 19, 12:34 PM
Someone with a lot of money to spend has taken a bearish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

BMY

Read More
3 minute read
  • Insider Trades
  • Markets
  • News
  • Trading Ideas

Amazon, Target And 3 Other Stocks Insiders Are Selling

By Lisa Levin
September 19, 9:17 AM
U.S. crude oil futures traded lower this morning on Monday. Investors, meanwhile, focused on some notable insider trades.

AMZN

Read More
2 minute read
  • Earnings
  • Eurozone
  • Futures
  • Global
  • Markets
  • News
  • Pre-Market Outlook
  • Small Cap

US Stock Futures Down Ahead Of Fed’s Rate Decision This Week, Crude Oil Drops Over 1%

By Lisa Levin
September 19, 5:32 AM
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Monday after recording losses on Friday. All the three major indices recorded losses last week, with the Dow Jones dropping 4.1% and the S&P 500 down 4.8%.

AZO

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

AutoZone, bluebird bio And 3 Stocks To Watch Heading Into Monday

By Lisa Levin
September 19, 4:09 AM
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

AZO

Posts navigation

Previous 1 … 6 7 8 … 39 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service